First-line Treatment with Empagliflozin and Metformin Combination Versus Standard Care for Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease in Qatar. A Cost-Effectiveness Analysis
Dina Abushanab, Daoud Al‐Badriyeh, Danny Liew, Zanfina Ademi
Topics & Concepts
EmpagliflozinMedicineMetforminType 2 Diabetes MellitusQuality-adjusted life yearType 2 diabetesDiabetes mellitusStroke (engine)Myocardial infarctionUnstable anginaEmergency medicineInternal medicineIntensive care medicineCost effectivenessEndocrinologyRisk analysis (engineering)EngineeringMechanical engineeringDiabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes Management and Research